CLSA Downgrades Emerson (EMR) to Sell
Tweet
Share
E-mail
Get Alerts EMR Hot Sheet
Price: $164.23 +0.35%
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
CLSA downgraded Emerson (NYSE: EMR) from Underperform to Sell.
For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.
Shares of Emerson closed at $53.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emerson (EMR) PT Raised to $186 at Bernstein SocGen Group
- Citi sees industrial growth at 6.9% in second quarter 2026
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
